You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AAV

Showing 376 - 397 of 397
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ANCA-associated Vasculitis Trial in London (Abatacept (Orencia))

Terminated
  • ANCA-associated Vasculitis
  • Abatacept (Orencia)
  • London, United Kingdom
    Imperial College London, Hammersmith Hospital
May 28, 2015

PRO Development for ANCA Associated Vasculitis

Unknown status
  • Wegener Granulomatosis
  • +2 more
    • Oxford, Oxfordshire, United Kingdom
      University of Oxford
    May 27, 2015

    CHF, Dilated Cardiomyopathy Trial in United States (MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study), Placebo

    Completed
    Has Results
    • Heart Failure, Congestive
    • Dilated Cardiomyopathy
    • MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)
    • +2 more
    • San Diego, California
    • +21 more
    Aug 19, 2014

    Parkinson's Disease Trial in San Francisco (AAV-hAADC-2)

    Completed
    • Parkinson's Disease
    • AAV-hAADC-2
    • San Francisco, California
      University of California, San Francisco
    Dec 2, 2013

    Multiple Myeloma Trial in Durham (Arsenic Trioxide, Ascorbic Acid and Bortezomib)

    Terminated
    • Multiple Myeloma
    • Arsenic Trioxide, Ascorbic Acid and Bortezomib
    • Durham, North Carolina
      Duke University Medical Center
    Jan 7, 2014

    Acute Intermittent Porphyria Trial in Pamplona, Madrid (rAAV2/5-PBGD vector dosage 1, rAAV2/5-PBGD vector dosage 2, rAAV2/5-PBGD

    Completed
    • Acute Intermittent Porphyria
    • rAAV2/5-PBGD vector dosage 1
    • +3 more
    • Pamplona, Navarra, Spain
    • +1 more
    Dec 17, 2014

    HIV Infection Trial in Belgium, Germany, India (tgAAC09)

    Completed
    • HIV Infection
    • tgAAC09
    • Antwerpen, Belgium
    • +4 more
    Jan 14, 2013

    Observational Study of Acute Intermittent Porphyria Patients

    Completed
    • Acute Intermittent Porphyria
      • Pamplona, Navarra, Spain
      • +1 more
      Mar 11, 2014

      Human Immunodeficiency Virus Infections, HIV Trial in South Africa, Uganda, Zambia (tgAAC09, Formulation buffer)

      Completed
      • Human Immunodeficiency Virus Infections
      • HIV Infections
      • tgAAC09
      • Formulation buffer
      • Cape Town, South Africa
      • +4 more
      Dec 13, 2012

      Duchenne Muscular Dystrophy Trial in Columbus (rAAV2.5-CMV-minidystrophin (d3990))

      Completed
      • Duchenne Muscular Dystrophy
      • rAAV2.5-CMV-minidystrophin (d3990)
      • Columbus, Ohio
        Columbus Children's Hospital
      Feb 4, 2013

      Muscular Dystrophies Trial in Columbus (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort, Genetic:

      Completed
      • Muscular Dystrophies
      • rAAV1.tMCK.human-alpha-sarcoglycan- First cohort
      • Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort
      • Columbus, Ohio
        The Research Institute at Nationwide Children's Hospital
      Feb 4, 2013

      Parkinson's Disease Trial in United States (Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus)

      Terminated
      • Parkinson's Disease
      • Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus
      • Stanford, California
      • +6 more
      Feb 20, 2012

      Limb Girdle Muscular Dystrophy Type 2C, Gamma-sarcoglycanopathy Trial in Paris (AAV1-gamma-sarcoglycan vector injection)

      Completed
      • Limb Girdle Muscular Dystrophy Type 2C
      • Gamma-sarcoglycanopathy
      • AAV1-gamma-sarcoglycan vector injection
      • Paris, France
        Hôpital Pitié-Salpêtrière
      Apr 28, 2011

      Long Term Follow-Up Study for rAAV-GAD Treated Subjects

      Terminated
      • Parkinson's Disease
      • rAAV-GAD
      • Stanford, California
      • +5 more
      Feb 20, 2012

      Familial Lipoprotein Lipase Deficiency Trial in Chicoutimi, Quebec (Alipogene Tiparvovec (AMT-011), Human LPL [S447X],

      Completed
      • Familial Lipoprotein Lipase Deficiency
      • Alipogene Tiparvovec (AMT-011), Human LPL [S447X]
      • +3 more
      • Chicoutimi, Quebec, Canada
      • +1 more
      Sep 28, 2011

      Familial Lipoprotein Lipase Deficiency Trial in Chicoutimi (Alipogene Tiparvovec (AMT-011), Human LPL [S447X], Mycophenolate

      Unknown status
      • Familial Lipoprotein Lipase Deficiency
      • Alipogene Tiparvovec (AMT-011), Human LPL [S447X]
      • +2 more
      • Chicoutimi, Quebec, Canada
        Ecogene-21 Clinical Trial Center/ Centre de santé et de services
      Sep 29, 2011

      Vasculitis, Microscopic Polyangiitis, Granulomatosis With Polyangiitis Trial in Cambridge (Alemtuzumab)

      Unknown status
      • Vasculitis
      • +3 more
      • Cambridge, United Kingdom
        Addenbrooke's Hospital, University of Cambridge NHS Foundation T
      Jul 28, 2011

      Arthritis, Rheumatoid, Arthritis, Psoriatic, Ankylosing Spondylitis Trial in United States (tgAAC94 gene therapy vector, tgAAC94

      Completed
      • Arthritis, Rheumatoid
      • +2 more
      • tgAAC94 gene therapy vector
      • tgAAC94 placebo
      • Glendale, Arizona
      • +21 more
      Jul 27, 2009

      Prostate Cancer Trial in Portland (GM-CSF gene transduced allogeneic vaccine GVAX)

      Unknown status
      • Prostate Cancer
      • GM-CSF gene transduced allogeneic vaccine GVAX
      • Portland, Oregon
        Providence Portland Medical Center
      Feb 23, 2009

      Parkinson's Disease Trial in Manhasset (Surgical infusion of AAV-GAD into the subthalamic nucleus)

      Completed
      • Parkinson's Disease
      • Surgical infusion of AAV-GAD into the subthalamic nucleus
      • Manhasset, New York
        North Shore University Hospital
      Mar 26, 2008

      Rheumatoid Arthritis Trial in Canada, United States (tgAAC94 gene therapy vector, tgAAC94 )

      Completed
      • Rheumatoid Arthritis
      • tgAAC94 gene therapy vector
      • tgAAC94 placebo
      • Los Angeles, California
      • +6 more
      Feb 5, 2008

      Hemophilia B Trial in Palo Alto, Philadelphia, Pittsburgh (Adeno-Associated Viral with Human Factor IX)

      Terminated
      • Hemophilia B
      • Adeno-Associated Viral with Human Factor IX
      • Palo Alto, California
      • +2 more
      Apr 2, 2007